BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2574908)

  • 21. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.
    Gremse DA
    Expert Opin Pharmacother; 2001 Oct; 2(10):1663-70. PubMed ID: 11825309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omeprazole and acid peptic disease.
    Piper DW; Yeomans ND; Shearman DJ
    Med J Aust; 1991 Mar; 154(6):374-5. PubMed ID: 2000048
    [No Abstract]   [Full Text] [Related]  

  • 26. The clinical safety of omeprazole.
    Sölvell L
    Scand J Gastroenterol Suppl; 1989; 166():106-10; discussion 111-3. PubMed ID: 2690327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
    Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
    Wilde MI; McTavish D
    Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Omeprazole. Its pharmacology and therapeutic efficacy].
    Protzer U; Holtermüller KH
    Dtsch Med Wochenschr; 1993 Feb; 118(7):230-9. PubMed ID: 8440164
    [No Abstract]   [Full Text] [Related]  

  • 30. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 31. H+/K+-adenosine triphosphatase inhibitors. A new approach to the treatment of acid-peptic diseases.
    Lamers CB
    Digestion; 1989; 44 Suppl 1():92-5. PubMed ID: 2691316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
    Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
    J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical development programme for omeprazole.
    Walan A
    Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omeprazole: implications for therapy of peptic ulcer and reflux oesophagitis.
    Bium AL
    Digestion; 1989; 44 Suppl 1():87-91. PubMed ID: 2691314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omeprazole in the treatment of duodenal ulcer.
    Bianchi Porro G; Parente F
    Scand J Gastroenterol Suppl; 1989; 166():48-53; discussion 74-5. PubMed ID: 2557670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
    Classen M; Dammann HG; Domschke W; Hüttemann W; Londong W; Rehner M; Simon B; Witzel L; Berger J
    Hepatogastroenterology; 1985 Oct; 32(5):243-5. PubMed ID: 3908262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histamine H2 receptor antagonists. Pharmacology and clinical applications].
    Mignon M; Gislon J; Bonfils S
    Rev Prat; 1978 Nov; 28(53):4145-6, 4151-2, 4155-8. PubMed ID: 33441
    [No Abstract]   [Full Text] [Related]  

  • 40. Omeprazole in the acute treatment of gastric ulcer.
    Schepp W; Classen M
    Scand J Gastroenterol Suppl; 1989; 166():58-62; discussion 74-5. PubMed ID: 2690333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.